IAIM
MDGL icon

International Assets Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

International Assets Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed -$5.6K – 2318
2024
Q2 		$5.6K Buy
+20
New +$4.76K ﹤0.01% 1818
2023
Q1 		– Sell
-1,014
Closed -$294K – 1288
2022
Q4 		$294K Buy
+1,014
New +$99.2K 0.03% 478

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

International Assets Investment Management's MDGL Position: Q3 2024 in Review

International Assets Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2024, closing a stake of 20 shares — an estimated $5.6K sold.

International Assets Investment Management first reported a position in MDGL in Q4 2022 and held it in 2 quarters. The position peaked at $294K in Q4 2022. 257 funds tracked by Wall St. Rank hold MDGL as of Q3 2024.

  • International Assets Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • International Assets Investment Management sold 20 Madrigal Pharmaceuticals shares in Q3 2024, an estimated $5.6K.
  • International Assets Investment Management first reported a position in Madrigal Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • International Assets Investment Management's Madrigal Pharmaceuticals position peaked at $294K in Q4 2022.
  • 257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.